many providers have revealed experiences of utilizing the RMCE system to provide monoclonal antibodies. In 2013, Genentech recognized a CRE centered monoclonal antibody expression platform for RMCE by screening transcriptional Energetic websites from the CHO genome (Crawford et al., 2013). Inserting a single expression cassette with heavy and light